About this trial
This clinical study aims to evaluate the clinical performance of 3M™ Filtek™ Supreme Flowable Composite in class IV and veneer indication. Follow-ups of 7 days, 6, 12, and 24 months will be conducted following an Fédération Dentaire Internationale (FDI) modified score (2023). A minimum of 50 Class IV and 25 veneers will be included in the evaluation. Research data and pictures will be provided for each patient pre-op and at 7 days (baseline, 6 months, 12 months and 24 months. Evaluation will be conducted by two calibrated evaluators different from the operator according to FDI clinical criteria.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age between 18 -75 years old
must be willing and able to provide informed consent to participate in the study
must be available for the required post-operative follow-up study visits
must be in good general health
Disqualifiers
Single tooth veneers
Canines
Periodontal disease
Pulpal diseases
Trial design
Parallel
Treatments tested in this trial
3MTM FiltekTM Supreme Flowable Composite
Device3M ™ Supreme Flowable Restorative contains BisGMA,TEGDMA and Procrylat resins. The fillers are a combination of ytterbium trifluoride filler with a range of particles sizes from 0.1 to 5.0 microns, a non-agglomerated/non-aggregated surface modified 20nm silica filler, a non-agglomerated/non/aggregated surface modified 75nm silica filler, and a surface modified aggregated zirconia/silica cluster filler (comprised of 20 nm silica and 4 to 11nm zirconia particles). The aggregate has an average cluster particle size of 0.6 to 10 microns. The inorganic filler loading is approximately 65% by weight (46% by volume). 3M (TM) Filtek(TM) Supreme Flowable Restorative is a modification of predicate device 3M(TM) Filtek(TM) XT Flowable Restorative (which was a modification of 3M(TM) Filtek(TM) Flow. 3M Filtek Supreme Flowable Composites are used per indication and its approved labeling in this study.
Treatment groups
Trial outcomes
Primary outcomes
Survival of treated site over 24 months
Primary site survival will be based off of an Modified FDI criteria score greater or equal to 4.
Secondary outcomes
Esthetic Properties evaluation
Esthetic quality scores measured on an ordinal scale of 1-5.
Functional Properties evaluation
Functional Properties scores measured on an ordinal scale of 1-5.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.